1110 related articles for article (PubMed ID: 17070117)
1. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
2. Salivary protein/peptide profiling with SELDI-TOF-MS.
Schipper R; Loof A; de Groot J; Harthoorn L; van Heerde W; Dransfield E
Ann N Y Acad Sci; 2007 Mar; 1098():498-503. PubMed ID: 17435159
[TBL] [Abstract][Full Text] [Related]
3. Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads.
Deng B; Dong Z; Liu Y; Wang C; Liu J; Wang C; Qu X
Clin Chim Acta; 2010 Aug; 411(15-16):1051-7. PubMed ID: 20361951
[TBL] [Abstract][Full Text] [Related]
4. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
5. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
6. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
Leung SM; Pitts RL
Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
[TBL] [Abstract][Full Text] [Related]
7. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI; He F; Cutrufello NJ; Lidow MS
Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
[TBL] [Abstract][Full Text] [Related]
8. Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis.
Papale M; Pedicillo MC; Thatcher BJ; Di Paolo S; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):205-13. PubMed ID: 17613287
[TBL] [Abstract][Full Text] [Related]
9. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform.
Shintani S; Hamakawa H; Ueyama Y; Hatori M; Toyoshima T
Int J Oral Maxillofac Surg; 2010 Jan; 39(1):68-74. PubMed ID: 19896329
[TBL] [Abstract][Full Text] [Related]
10. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.
Schaub S; Wilkins J; Weiler T; Sangster K; Rush D; Nickerson P
Kidney Int; 2004 Jan; 65(1):323-32. PubMed ID: 14675066
[TBL] [Abstract][Full Text] [Related]
11. In-source decay causes artifacts in SELDI-TOF MS spectra.
Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C
J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843
[TBL] [Abstract][Full Text] [Related]
12. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
[TBL] [Abstract][Full Text] [Related]
13. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study.
Ciavarella D; Mastrovincenzo M; D'Onofrio V; Chimenti C; Parziale V; Barbato E; Lo Muzio L
Prog Orthod; 2011 Nov; 12(2):126-31. PubMed ID: 22074837
[TBL] [Abstract][Full Text] [Related]
14. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
15. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
16. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.
Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA
J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040
[TBL] [Abstract][Full Text] [Related]
17. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
[TBL] [Abstract][Full Text] [Related]
18. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
[TBL] [Abstract][Full Text] [Related]
19. Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry.
Zhou M; Prieto DA; Lucas DA; Chan KC; Issaq HJ; Veenstra TD; Conrads TP
J Proteome Res; 2006 Sep; 5(9):2207-16. PubMed ID: 16944932
[TBL] [Abstract][Full Text] [Related]
20. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]